ACC GUIDELINES Bundle

Cardiovascular Risk Assessment

ACC GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/277546

Contents of this Issue

Navigation

Page 2 of 5

Diagnosis Diagnosis Table 1. Recommendations for Risk Assessment Recommendations ACC/AHA COR ACC/AHA LOE e race- and sex-specific Pooled Cohort Equations a to predict 10-year risk for a first hard ASCVD event should be used in non- Hispanic African Americans and non-Hispanic Whites, 40-79 years of age. I B Use of the sex-specific Pooled Cohort Equations for non- Hispanic Whites may be considered when estimating risk in patients from populations other than African Americans and non-Hispanic Whites. IIb C If, aer quantitative risk assessment, a risk-based treatment decision is uncertain, assessment of 1 or more of the following— family history, hs-CRP, CAC score, or ABI—may be considered to inform treatment decision making. (See Table 2) IIb b B e contribution of ApoB, CKD, albuminuria, and cardiorespiratory fitness to risk assessment for a first ASCVD event is uncertain at present. N/A N/A Routine measurement of CIMT is not recommended in clinical practice for risk assessment for a first ASCVD event. III: No Benefit b B It is reasonable to assess traditional ASCVD risk factors c every 4-6 years in adults 20-79 years of age who are free from ASCVD and to estimate 10-year ASCVD risk every 4-6 years in adults 40-79 years of age who are free from ASCVD. IIa B Assessing 30-year or lifetime ASCVD risk based on traditional risk factors c may be considered in adults 20-59 years of age who are free from ASCVD and are not at high short-term risk. IIb C a Derived from the Atherosclerosis Risk in Communities (ARIC) study, Cardiovascular Health Study (CHS), Coronary Artery Risk Development in Young Adults (CARDIA) study, Framingham original and offspring cohorts. b Based on new evidence reviewed during ACC/AHA update of evidence. c Age, sex, total cholesterol, high-density lipoprotein cholesterol, systolic BP, use of antihypertensive therapy, diabetes, and current smoking.

Articles in this issue

Archives of this issue

view archives of ACC GUIDELINES Bundle - Cardiovascular Risk Assessment